<DOC>
	<DOCNO>NCT01758562</DOCNO>
	<brief_summary>Randomized control study efficacy mouth rinse Caphosol patient allogeneic stem cell transplantation . 85 % patient receive severe oral mucositis due treatment . 70 patient randomize intervention ( Caphosol ) standard ( state-of-the-art ) group . Primary endpoint duration mucositis , secondary endpoint occurence oral mucositis measure WHO-scale occurence pain measure NRS-scale ( Numeric Rating Scale ) . - Trial medical device</brief_summary>
	<brief_title>Caphosol® Versus State-of-the-art Mouthcare Patients With Allogeneic Stem Cell Transplantation : Randomized Controlled Study About Efficacy Mouth Rinse Caphosol®</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Allogeneic stem cell transplantation Male female patient age 1880 Signed inform consent information Exclusion criterion : Contraindications due ethical reason Unable read write Unable speak understand german language Lowsalt diet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>